These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 3805329

  • 1. Desipramine in the treatment of children with attention deficit disorder.
    Biederman J, Gastfriend DR, Jellinek MS.
    J Clin Psychopharmacol; 1986 Dec; 6(6):359-63. PubMed ID: 3805329
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A naturalistic study of 24-hour electrocardiographic recordings and echocardiographic findings in children and adolescents treated with desipramine.
    Biederman J, Baldessarini RJ, Goldblatt A, Lapey KA, Doyle A, Hesslein PS.
    J Am Acad Child Adolesc Psychiatry; 1993 Jul; 32(4):805-13. PubMed ID: 8340302
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Tourette's syndrome with symptoms of attention deficit disorder treated with desipramine.
    Linet LS.
    J Clin Psychiatry; 1987 Nov; 48(11):456. PubMed ID: 3479424
    [No Abstract] [Full Text] [Related]

  • 10. Desipramine in the treatment of attention deficit disorder in adolescents.
    Gastfriend DR, Biederman J, Jellinek MS.
    Psychopharmacol Bull; 1985 Nov; 21(1):144-5. PubMed ID: 3983334
    [No Abstract] [Full Text] [Related]

  • 11. Possible influence of carbamazepine on plasma imipramine concentrations in children with attention deficit hyperactivity disorder.
    Brown CS, Wells BG, Cold JA, Froemming JH, Self TH, Jabbour JT.
    J Clin Psychopharmacol; 1990 Oct; 10(5):359-62. PubMed ID: 2258453
    [Abstract] [Full Text] [Related]

  • 12. A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder.
    Biederman J, Melmed RD, Patel A, McBurnett K, Konow J, Lyne A, Scherer N, SPD503 Study Group.
    Pediatrics; 2008 Jan; 121(1):e73-84. PubMed ID: 18166547
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hallucinations and other psychotic symptoms associated with the use of attention-deficit/hyperactivity disorder drugs in children.
    Mosholder AD, Gelperin K, Hammad TA, Phelan K, Johann-Liang R.
    Pediatrics; 2009 Feb; 123(2):611-6. PubMed ID: 19171629
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.